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Abstract:  
K-Ras, a member of the Ras superfamily GTPases, plays a key role in regulating cellular growth, 
and single point mutations in this protein that promote chronic activation are found in 
approximately 30% of human cancers.1 Recent findings have suggested that post translational 
modifications such as monoubiquitination of KRas can alter its intrinsic activity.2 This project 
invstigated the effects of mUbRas104, the minor site of native in vivo modification, in the context 
of its impact on protein structure and activity relative to that of WT KRas and mUbRas147.  The 
structural changes of mUbRas104 were characterized using NMR techniques and Rosetta 
modeling, and the protein’s activity was characterized through various biochemical assays. From 
the NMR data, chemical shift perturbations, broadening, and changes in secondary structure 
were observed throughout the protein.  Perturbations in the switch regions are consistent with a 
slightly disturbed binding affinity to downstream effector proteins, but are more localized in 
switch II and helix 3, contrary to the predominant switch I perturbations found in mUbRas147.  
These findings suggest that mUbRas104, as a minor site of monoubiquitination, does not cause the 
same magnitude of functional disturbances as does mUbRas147. From these experiments, a 
protocol was also developed to irreversibly ligate the ubiquitin molecule, and this protocol can 
now allow this system to be studied in vivo for future work.  
 
Introduction:  
Ras GTPases function as molecular switches by cycling between inactive GDP- and active GTP-
bound states to regulate cellular growth control.  They are part of a large (>150 member) 
superfamily of proteins that bind guanine nucleotides, GDP and GTP, with high affinity and 
hydrolyze bound GTP to GDP.3 When GTP is bound, Ras undergoes a conformational change 
that promotes higher affinity binding to downstream targets relative to the GDP-bound state. 
These changes in conformation occur in two distinct switch regions, switch I (residues 30–37) 
and switch II (60–76).  Both of these switch regions engage downstream effector proteins.4 The 
Raf kinase is a key downstream effector of Ras that promotes MAP Kinase regulation to alter 
gene transcription.1  It contains Ras binding domain (RBD) used in this work and binds strongly 
to the switch I region in the active Ras-GTP state with 105 fold higher affinity relative to the 
GDP bounds state.4 Ras has a low intrinsic ability to hydrolyze its own bound GTP, however, 
hydrolysis is greatly stimulated by GTPase Activating Proteins (GAPs).2 These proteins help Ras 
hydrolyze its bound GTP into GDP, rendering the Ras inactive.  The process of activating the 
protein involves regulation using Guanine nucleotide Exchange Factors (GEFs), to facilitate 
exchange of bound GDP with GTP, thus activating the Ras molecule.  Mutations that interfere 
with this GEF/GAP mechanism can lead to Ras becoming constitutively active.  The hyper 
activation of GEF or inhibition of GAP can lead to deregulated cell proliferation and cancer.2 
 
Extensive research has been conducted in the past to investigate common single residue 
mutations and their effects on Ras activity.  These single point mutations have been well 
documented to inhibit nucleotide exchange and/or catalysis, promoting Ras signaling and cell 
proliferation. However, in recent years, surface lysine post translational modifications (PTMs) 
have been found to also significantly alter Ras function.5 These modifications include 
methylation, acetylation, and ubiquitination at specific lysine residues including residues 5, 104, 
117 and 147. These residues and PTM’s at these sites are conserved across HRas and KRas 
variants but exhibiting varying function effects. For example, monoubiquitination, the ligation of 
a single ubiquitin protein through a linker, of HRas affects its association with endosomes 
whereas modification of KRas at 117 and 147 can promote Rasopathies and cancer.6 Previous 
research from our lab investigated the functional consequences of monoubiquitination on KRas 
at residues 104, 117, and 147 (mUbRas104, mUbRas117 and mUbRas147).2,7 Our work concluded 
that post translational modification at 147 caused an increased in the accumulation of GTP bound 
Ras despite not affecting Ras stability or intrinsic catalytic activity. The accumulation was 
instead caused by inhibition of GAP mediated hydrolysis due to a decreased binding affinity of 
GAPs to Ras.   
 
Lysine 104 is a hot spot for PTMs such as acetylation or monoubiquitination, but its functional 
effects are less understood than modification at other sites.7 Contrary to the modification at 
Ras147, investigations into mUbRas104 previously showed that Ras retains normal GEF/GAP 
activity.7 However, activity tests conducted on the non-ubiquitinated K104C Ras showed a 
decrease in GEF activity due to the absence of a key electrostatic interaction between the surface 
lysine that stabilizes two helices within Ras. This electrostatic interaction occurs between the 
side chain of K104 and the backbone carbonyl groups of R73 and G75 in switch II, which helps 
stabilize the orientations of helix 2 (H2) and helix 3 (H3), and any mutation at this lysine 104 has 
been shown to cause a GEF defect.8 As ubiquitylation at 104 will also perturb this interaction, 
likely destabilizing interactions between H2 and H3, a known binding interface for GEFs, we 
hypothesize that ubiquitylation at 104, stabilizes this key Ras-GEF interface through a crowding 
mechanism.   
 
This project expands on the previous research and aims to characterize the effects of 
monoubiquitination at Ras104 through the ligation of a ubiquitin protein to KRas with a disulfide 
bond. We will use NMR 2D and 3D studies to characterize chemical shift changes and quantify 
changes in secondary structure between WT KRas and mUbRas104 using isotopically enriched 
protein. In addition, we will perform biochemical activity assays using fluorescent nucleotides to 
measure the relative effector binding strength of ubiquitin-modified Ras and measure the GEF 
exchange rates using a real time NMR approach. To test our hypothesis that crowding by 
ubiquitin will restore RasK104C GEF function through an occlusion effect, we will use TMAO, a 
protein crowding agent and measure its effects on RasK104C activity through the aforementioned 
assays. Our characterization studies aim to reveal how ubiquitination of KRas at lysine 104 
promotes conformational/dynamic changes in the switch regions and helix 3 to retain GEF 
activity to RasK104C.  
 
Experimental Methods:  
Constructs:  
 
The human cDNA sequence that encodes the G-domain of each Ras mutant (C118S and K104C 
residues 1-169) was subcloned into a pET21 vector. The human cDNA that encodes the SOS1 
gene (SOScat) was subcloned into a pQlinkH vector. The human cDNA that encodes the 
Ubiquitin mutant (G76C) was subcloned into a pQlinkH vector. All vectors add a TEV protease 
cleavage site and N-terminal 6x-histidine tag to the sequence.   
 
 
 DNA Transformation for expression in bacteria:  
The main proteins of interest were RasC118S (1-166), RasK104C (1-166), UbiquitinG76C, bRaf, and 
the GEF Soscat. RasC118S has a surface cysteine at 118 modified to a serine to limit possible 
dimerization or oxidation. Previous research had shown that this modification did not alter any 
structure or function compared to true wildtype KRas, so RasC118S was used as the wildtype 
control for the rest of the experiments.2 The DNA for these proteins had previously been created 
through recombination and were sequence confirmed. The desired DNA (1µL) was mixed with 
competent cells.  BL21DE3 RipL was used for the expression of Ras and other effectors while 
BL21DE3 pLysS was used for the expression of ubiquitin. The cells were incubated on ice for 25 
minutes, heat shocked at 42°C and then placed back on ice for two minutes.  They were then 
plated on LB Agar plates containing antibiotic and incubated at 37°C for 16-24 hours.   
 
Protein Expression: 
 
LB media (1L) was autoclaved (10 g Trypton powder, 10 g NaCl, 5 g Yeast extract), and 40 mLs 
of LB was used to make the starter cultures. The proper antibiotic was added along with a single 
colony from the plate of interest using a flame sterilized inoculating loop.  These starter cultures 
were grown overnight at 280 rpm at 25°C.  Optical density (OD) at 600 nm was checked the next 
day, and if it reached a growth greater than 1.0, the culture was spun down to a pellet. The pellet 
was resuspended in 1L of LB containing Ampicillin and Chloramphenicol. This was incubated in 
the shaker at 225 rpm at 37°C. When OD reached 0.55, the flasks were placed on ice to slow 
growth and the shaker was cooled to 18°C.  (Ubiquitin growth did not involve cooling and 
continued overnight at 37°C). Once cooled, the flasks were placed back into the shaker and each 
culture was induced with 800 µL of 0.5 mM IPTG.  Growth was allowed to continue overnight 
and the culture was collected the next day by spinning the culture down at 4000 RPM for 25 
minutes. The pellet was suspended in 40 mLs of the respective wash buffer (20 mM Hepes, 300 
mM NaCl, 5 mM MgCl2, 20 mM imidazole, 10 µM GDP, 5% glycerol, pH 7.75 for KRas/SosCat 
and 30 mM Hepes, 150 mM NaCl, 5mM MgCl2, 10 mM imidazole, pH 8.0 for Ubiquitin/bRaf) 
used for purification and stored.  
 
If isotopically labeled proteins (15N or 15N/13C-enriched Ras) were needed for NMR, M9 
minimal media was used for growth instead of LB.  M9 media was prepared by adding 2.0 mL 
1.0 M MgSO4, 500 µL 1.0 M CaCl2, 168 µL 0.3 M ZnSO4, 10 mL of 100x sterile filtered 
vitamins (5 mg biotin, 5 mg choline chloride, 5 mg folic acid, 5 mg niacinamide, 5 mg D-
pantothenate, 5 mg pyridoxal, 0.5 mg riboflavin, 50 mL H2O), 90 mg thiamine and 1X of the 
proper antibiotics to 100 mL of autoclaved 10x M9 salts (pH 7.4) and 885 mL ddH20. Depending 
on the labeling, 1 g of 15N NH4Cl, and/or 2 g 13C Glucose were added. The steps for overnight 
cultures, induction and collection remain the same.  
 
Protein Purification:  
Two separate protocols were used for purification, one for the Ubiquitin/bRaf, and one for 
KRas/Soscat; both involved nickel column and His tag affinity chromatography. 2.5 mM TCEP 
reducing agent was added to all steps of purification for UbiG76C, RasK104C and RasK147C. The 
desired cell culture was sonicated with cOmplete ULTRA Tablet protease inhibitor cocktail and 
spun down.  
 
KRas/SosCat purification -  The nickel column was equilibrated with buffer A (20 mM Hepes, 
300 mM NaCl, 5 mM MgCl2, 20 mM imidazole, 10 µM GDP, 5% glycerol, pH 7.75).  The 
supernatant was then added to the column. The protein on the column was washed with buffer A, 
followed by buffer B (20 mM Hepes, 1M NaCl, 5mM MgCl2, 40 mM imidazole, 10 µM GDP, 
5% glycerol pH 7.75), then another wash using buffer A, before eluting with buffer C (15 mM 
Hepes, 50 mM NaCl, 5 mM MgCl2, 250 mM imidazole, 10 µM GDP pH 7.75).  Fractions were 
collected for each wash phase, and samples were mixed with reducing dye for an SDS-PAGE gel 
run later to confirm expression and yield.  
 
Ubiquitin/bRaf purification – The nickel column was equilibrated with wash buffer (30 mM 
Hepes, 150 mM NaCl, 5mM MgCl2, 10 mM imidazole, pH 8.0 ).  The supernatant was then 
added to the column and a gradient elution was applied using wash buffer and elution buffer (20 
mM Hepes, 1M NaCl, 5 mM MgCl2, 250 mM imidazole, pH 8.0). The gradient ran from 100% 
wash 0% elution to 85% wash and 15% elution for 160 mL. The protein was then eluted using 
100% elution buffer. Fractions were collected for each wash phase, and samples were mixed 
with reducing dye for an SDS-PAGE gel run later to confirm expression and yield.  
 
The collected protein fraction was then transferred into a dialysis membrane. The Ras or Soscat 
proteins were placed in membranes with cutoffs at 8.0 kDa whereas Ubiquitin or bRaf proteins 
were placed in 3.5 kDa cutoff membranes. Once transferred, an excess of TEV protease was 
added to the dialysis membrane.  The membrane was then sealed, placed in dialysis buffer, and 
allowed to undergo dialysis overnight in the cold room. The next day, a gel was run of sample to 
determine TEV cleavage efficiency along with the wash fractions from the previous day. The 
protein was collected by running it through the nickel column again if the protein successfully 
had its His-tags cleaved.  
  
If needed, protein was further purified by size exclusion on a Sephadex G-75 column using fast 
protein liquid chromatography, FPLC buffer (50 mM Hepes, 150 mM NaCl, 5 mM MgCl2, 15 
µM GDP pH 7.75).   
 
Concentration Determination 
The concentration of proteins was determined by measuring the absorbance using a Shimadzu 
UV-2501 PC UV-Vis Spectrophotometer at A280 in a 500 µL quartz cuvette with a path length 
of 1 cm. The protein was first spun down at on a high-speed tabletop centrifuge to pellet any 
debris. Protein concentration was then determined using Beers law with the molar extinction 
coefficient for Ras at 19920 M-1cm-1 and for Ubiquitin at 1420 M-1cm-1. 
 
Ubiquitination Reaction using Reversible Disulfide:  
RasK104C and UbiG76C were combined together in a Ras to Ubiquitin ratio of 1:10, and buffer 
exchanged 4 rounds with the reaction buffer (50mM Tris, 50 mM NaCl, 5 mM MgCl2, 10 µM 
GDP pH 7.85). After the sample was concentrated down to a final volume of 1 mL, it was 
transferred to a dialysis membrane with 3.5 kDa cutoff. A small amount of the Ras:Ubiquitin 
mixture is mixed with non-reducing loading dye and kept as a control. Two liters of 
ubiquitination buffer were split into two 1L beakers, and the dialysis bag was placed into one of 
them.  Dialysis was allowed to occur for 3-4 hours, at which point, the ubiquitination buffer was 
switched out for the other liter and allowed to dialyze overnight at 4°C.  Two samples were taken 
the next day and one is mixed with reducing dye while the other is mixed with non-reducing.  
These were run on an SDS-PAGE gel to check if the reaction occurred successfully and all of the 
Ras had reacted. If not, more ubiquitin was buffer exchanged and added to the reaction mixture 
until all of the Ras had successfully ligated.   
 
Ubiquitination Reaction using Irreversible Linker-DCA: 
 
A separate protocol was developed to irreversibly ligate RasK147C and UbiG76C using a 1,3 
dichloroacetone (DCA) linker. Ras and Ubi were separately buffer exchanged into reaction 
buffer (20 mM sodium borate, 5 mM MgCl2, 40 µM GDP 7 mg/50 mL TCEP pH 8.7). The 
proteins were concentrated down to less than 200 µL and were combined in a 1:3 Ras:Ubi ratio 
(roughly 0.7 mM Ras; 2 mM Ubi) . DCA was added so the final concentration of DCA was 0.8 
mM and the reaction was allowed to proceed overnight on rotator. The reaction was checked the 
following day for completion using SDS-PAGE and reducing dye. The mUbRas147 is then 
isolated using a Sephadex G-75 column, FPLC buffer (50 mM Hepes, 150 mM NaCl, 5 mM 
MgCl2, 15 µM GDP pH 7.75).   
 
 
Nucleotide Loading: 
Nucleotide loading was performed using a fluorescent non-hydrolysable GTP analog Mant-
GMPPCP.  The Ras proteins were first buffer exchanged 4 times into the loading buffer (20 mM 
Hepes, 0.25 mM MgCl2, 50 mM NaCl pH 7.4) Once the samples were concentrated down to a 
volume of  less than 700 µL, 500 µL of Alkaline Phosphatase (AP) beads, 100 µL ZnCl2, 100 
mM (NH4)2SO4, 0.25 mM EDTA, and 0.02% NaN3 were added to an UV protected Eppendorf 
tube along with the GTP nucleotide so that the final ratio of Ras to nucleotide was 1:5. This tube 
was placed in a rotator and the exchange proceeded overnight. 50 µL was removed and boiled 
down initially to serve as a reference for the progress of the loading.  
 
The next day, the AP beads were spun down out of solution and the supernatant transferred to a 
10 kDa Amicon centrifuge tube for four rounds buffer exchange with Mant dissociation buffer 
(20 mM Hepes, 50 mM NaCl, 5 mM MgCl2 pH 7.4).  The loading was checked the next day 
using an HPLC machine from Agilent Technologies on a C-18 bonded silica column using 
reverse phase liquid chromatography. The HPLC sample was prepared by boiling 50 µL of the 
protein and spinning it down for 5 minutes at 13000 rpm to denature and pellet the protein.  The 
supernatant was run on the column along with Mant-GMPPCP and GDP as references.  
Successful loading showed a very small GDP peak with a large increase in a third GMP peak due 
to the AP cleavage of bound GDP. For all steps following successful loading, the fluorescent 
nucleotides were protected from UV light by using aluminum foil to cover the tubes.   
 
 
 
 
Fluorescent Binding Assays:  
Following loading, binding assays were set up using the loaded Ras and purified bRaf.  The bRaf 
was first exchanged 4x with the Mant dissociation buffer. PCR strip tubes were then laid out for 
a total of 12 different reactions for each Ras protein. The ligand concentrations ranged from 0.0 
to 14.0 µM. Each reaction tube contained 1.5 µM Ras and its respective concentration of ligand 
in a final reaction volume of 90 µL. 500 µM of GDP was added right before running the assay to 
ensure capture of the beginning data points.  Each reaction was split into two wells on a 384 well 
plate and the plate was read by a SpectraMax M5 plate reader.  Readings were taken at 25 
second intervals for 2 hours with the excitation wavelength set at 335 nm and emission 
wavelength at 448 nm. Results for each run was normalized to the maximum florescence and the 
rates were fitted to a one phase exponential decay curve to obtain the binding constant.   
 
In the binding experiments using Trimethylamine N-oxide (TMAO), 0.5M of TMAO was added 
to the reaction volume.   
 
NMR Experiments  
NMR experiments were conducted by buffer exchanging the 15N or 15N13C enriched protein into 
NMR buffer (20 mM Tris-Maleate, 50 mM NaCl, 5 mM MgCl2 pH 6.5) with 5% D2O and 20 
µM GDP.  The experiments were conducted at 25 °C on either the Bruker Avance III 700 or 850 
MHz NMR spectrometers. 2D 1H-15N HSQC experiments were recorded for both WT and 
mUbRas104 bound to GDP, and average 1H-15N chemical shift perturbations were calculated 
according to the square root of ((Δσ 1H)2 + (Δσ 15N)2/25), where Δσ 1H and Δσ 15N are the 
observed changes in 1H and 15N chemical shifts. 
 
Backbone resonance assignments of mUbRas104 were obtained by analysis of 3D HNCA spectra 
recorded on 13C,15N-labeled mUbRas104 bound to GDP. The assignment of Cα, N, and HN 
chemical shifts was obtained by an iterative procedure using the program MARS and manual 
inspection and using WT KRAS assignments.9 For CSI, ΔCα values were calculated by 
subtracting experimental chemical shifts of Cα from random coil values obtained from the  
ncIDP (neighbor-corrected intrinsically disordered protein) server.10 
 
Real Time NMR  
Real time NMR experiments were used to analyze Ras nucleotide exchange and hydrolysis rates 
for WT and mUbRas104. 2D 1H-15N HSQC experiments were set up sequentially on either the 
Bruker Avance III 700 or 850 MHz NMR spectrometers at 20°C.  Hydrolysis experiments were 
done by first exchanging the protein into NMR exchange buffer (20 mM Tris-Maleate, 50 mM 
NaCl, 5 mM MgCl2 pH 7.0) and GTP using 1:1 EDTA:Mg at room temperature for 1 hour. Any 
excess GTP was separated after loading by running the protein through a PD-10 desalting 
column.  The sample was then taken to NMR and a series of HSQC experiments were queued 
over the span of 9+ hours with a low number of scans (n<4) to obtain several spectra. GEF 
exchange assays were performed by queueing up several HSQC experiments on the GDP bound 
form of Ras. The protein were exchanged into NMR exchange buffer and 1:15 Ras:GTP, 17:1 
Ras:Soscat were added right before the start of acquisition at 293K.    
 
During exchange, two distinct peaks can be seen for specific residues, each corresponding to 
either a GDP or GTP population.  Using Topspin software, the peak intensity for S118-GDP and 
S145-GDP were recorded and divided by S118-GTP and S145-GTP peak intensity respectively 
to obtain the relative population of each Ras-GTP or Ras-GDP bound state. These data points 
were then fitted to a one phase association or dissociation curve to obtain the rates of association 
or hydrolysis.   
 
Results:  
 
Generation of mUbRas system 
The project heavily relied on the ability to reliably generate mUbRas104, and this process took 
several months to optimize, but now a protocol has been developed to consistently generate this 
system. To study site specific monoubiquitination at residue 104, chemical ligation through the 
formation of a disulfide bond between the terminal cysteine on the tail of UbiG76C and the surface 
cysteine on the mutant RasK104C was achieved.  The exposed cysteines were very sensitive to 
oxidation and must be kept reduced using TCEP.  The pH was shifted to 7.85 during the reaction 
to increase strength of the nucleophile, and the cell line for Ubiquitin expression was changed to 
pLyss to prevent oxidation.  After the generation of the mUbRas104 by titrating out the reducing 
agent, no further purification steps were taken once the mUbRas complex was formed since 
previous research had demonstrated Ubi-Ubi and free Ubiquitin does not interfere with Ras 
function.2 
 
Figure 1. SDS-PAGE separating the overnight reaction products of the RasK104C-UbiG76C  
disulfide reaction. Two samples were taken after initially mixing the proteins together and 
combined with reducing (R) and non-reducing (NR) dye to serve as a reference in lanes from 
Day1.  After overnight of dialysis to remove TCEP, almost all of the Ubiquitin has dimerized or 
formed mUbRas. This can be seen in the Day 2 lane with the non-reducing dye.  The reduced 
lane of Day 2 shows that all of the original protein was still present and no degradation occurred.  
 
Development of DCA covalent monoubiquitination reaction  
Since the previous ligation strategy is heavily sensitive to reducing environments, and is 
reversible, a new method was adapted from Morgan et al. 2012 to generate monoubiquitination 
using an irreversible linker.11 In this method, the cysteines on both proteins perform nucleophilic 
attack the terminal carbons of DCA and does an SN2 replacement of the chlorines.   
 
 
 
 
 
 
 
 
 
This reaction was optimized with regard to protein concentration, reaction time, pH, and DCA 
concentration.  This method was used to generate mUbRas147 in large quantities and isolated 
through S75 gel filtration, something previously not possible with the disulfide bond method due 
to the need of excess ubiquitin in solution to drive the equilibrium toward mUbRas bond 
formation. This method was only developed toward the end of the experiments, so all data 
presented was conducted using the disulfide ligation system.  R. Thurman conducted bRaf 
binding experiments using mUbRas generated using this method and confirmed the properties 
parallel that of mUbRas disulfide system.   
 
Figure 2. SDS Gel showing ubiquitination using the DCA method. Samples in 3 lanes were 
taken at various reaction times, initial, 2 hr, and overnight, and show a significant amount of 
mUbRas forming as a function of addition time.  Concentrations of protein need to be higher for 
this method to ensure reaction (0.7 mM RasK147C and 2.1 mM UbiG76C).   
 
NMR data of mUbRas104 shows NMR chemical shift perturbations and changes to secondary 
structure in switch II and Helix 3 
 
Once the method for reliably generating mUbRas104 was created, 13C and 15N-enriched RasK104C 
was grown and reversibly monoubiquitinated using the disulfide method to perform 3D HNCA 
NMR and obtain backbone assignments.  Using Mars and manual Ca alignment peak picking, 
141 out of 169 possible peaks were assigned for mUbRas104. These assignments were then used 
to map chemical shift perturbations and broadening relative to WT HSQC data.  
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Figure 3. Monoubiquitination of KRas-GDP at 104 causes NMR perturbations within the 
Switch regions and Helix 3. 1H-15N 2D NMR HSQC of mUbRas104 (blue) and WT KRas (red). 
Spectra were recorded using a Bruker Avance III 700 at 25 °C on 0.1 mM KRas WT and 
mUbRas104 bound to GDP. 
 
 
 
 
 
 
 
Figure 4. Monoubiquitination of KRas 
at 104 causes structural perturbations 
in helix 2 and helix 3. (A) NMR analyses 
of peak shifts reveal that the mUbRas104 
causes large CSPs in switch II and 
neighboring residues in helix 3 but minor 
changes in β1 within switch 1. CSP was 
calculated based on weighted average 
chemical shift (square root of ((Δσ 1H)2 + 
(Δσ 15N)2/25)) of WT and mUbRas104 NH 
peaks in 1H-15N 2D HSQC NMR 
spectra. (B) differences in secondary 
structure determined from Cα and Cβ 
chemical shift indexing indicate that 
mUbRas104 causes perturbation to the 
local conformation surrounding 104 in H3 
and the α2 helix (residues 71–74) within 
switch II. (C) The difference in chemical 
shift indexing between mUbRas104 and 
WT KRAS indicates that the KRAS 
ubiquitination perturbs the local 
conformation surrounding 104 in H3 and 
the α2 helix (residues 71–74) in switch II. 
(D) Intensity plot from GDP HSQC of 
mUb104 compared to WT.  Plot shows 
pattern of broadening in Beta-1, SWI, 
SWII, and neighboring regions of 104 
indicating that monoubiquitination 
modulates switch dynamics.    
 
The perturbations and broadening in the switch regions suggest changes in the electrochemical 
environment and dynamics that may affect regulator and effector recognition. Broadening seen 
in the switch regions and helix 3 indicate a change from fast exchange on the NMR time scale to 
a more intermediate/slow time scale. This trend indicates that these regions are more constrained 
and rigid in dynamics, possibly due to the steric bulk of the ubiquitin.  Secondary carbon 
chemical shift data show a loss of helical secondary structure in helix 2 and 3. 
 
Exchange data shows a loss of intrinsic hydrolysis, maintains its GEF exchange rate 
 
Due to fluorescence quenching observed when attempting to perform fluorescence-based 
exchange assays as described in Baker et al. 2013, a real time NMR method was instead 
established from Smith et al. 2015 for GEF exchange.7,12 The rate of intrinsic GTP hydrolysis 
was also needed since the GEF exchange occurred over a time frame of 3 hours, where the 
intrinsic hydrolysis rate of Ras could affect the readings. The data was plotted according the time 
between the acquisitions with relation to the relative GDP/GTP populations of Ras.   
 
         
Figure 5. Ubiquitination retains Sos mediated exchange (A). Nucleotide exchange of WT and 
mUbRas104 in the presence of SosCat. Ras was bound to GDP and incubated with access of GTP 
at ratio of 15:1 and the presence of SOS (Ras:Sos 1700:1). (B). Sos-mediated exchange rates 
shows that mUbRas104 has higher but not significantly different in exchange rate relative to Ras 
WT. (C) mUbRas104 shows 3-fold decrease in intrinsic hydrolysis relative to WT. (D) Difference 
spectra of 1H-15N HSQC of KRas-bound to GDP and GTP demonstrates the peak trackability 
that can be used to measure the real-time nucleotide exchange. %Exchanged and %Hydrolyzed 
were determined by GDP intensity/(GDP+GTP intensity) for each spectra acquisition with 
respect to the time of the acquisition. Results are mean ± S.E. (n=2).  
 
D. 
The data presented in Figure 5 reflects previous published data that mUbRas104 retains its GEF 
exchange ability despite the chemical shift perturbations in the binding regions.   
 
Table 1. Relative fold differences in rates of Sos exchange and hydrolysis for mUbRAS104 
compared to WT.  (+) indicates increased rate while (–) represents slower rate. 
 mUbRas104 
Sos Exchange +1.31 ± 0.11 
Intrinsic Hydrolysis -3.16± 0.13 
 
RBD binding data shows weakened binding, consistent with perturbations in the switch regions, 
but TMAO crowding effects could explain previous observations of mUbRas restoring GEF 
function  
 
Following the exchange experiments, fluorescence based binding assays were conducted using 
the GTP bound form of the proteins to determine how monoubiquitination effects  binding 
affinity to downstream effectors. Consistent with changes in CSP and dynamics of the switch 
regions observed by NMR, binding to the bRaf RBD decreased a relatively small amount by 3-
fold.  To test the hypothesis that mUbRas104 retains GEF interactions despite loss of electrostatic 
interactions between helix 2 and helix 3 via a crowding effect, a crowding agent TMAO was 
used by the suggestion of A. Guseman. Consistent with this premise, the presence of TMAO 
partially restores binding. Once TMAO is added, the RasK104C binding is enhanced 2-fold to 
reflect that of  mUbRas104, while the binding of WT is not enhanced significantly. These results 
reflect the prediction that the Ubiquitin molecule, through contacts with Ras, may act as a 
crowding agent through an occlusion effect and cause Ras to adopt a conformation that facilitates 
GEF binding.   
 
Figure 6. mUbRas104 reduces binding to effectors in comparison with the WT KRas.  
The binding affinity of KRAS WT and mUbRas104 to CRAF RBD was determined by loading 
KRAS proteins with MANT-GMPPCP and measuring nucleotide release rates as a function of 
effector protein concentration. To determine the affinity (KD) for the KRAS-effector complex, 
the data were fitted to a standard curve. mUbRas104 is shown to have three-fold weaker binding 
to cRaf, while RasK104C has roughly six-fold weaker binding. However, in the presence of 
TMAO, a crowding molecule, RasK104C binding to cRaf is enhanced, due to being in a tighter 
conformation, similar to what is predicted by monoubiquination. Relative binding affinity to 
KRAS WT is shown in Table 2. The results are reported as the fold binding affinity, weaker (-), 
stronger (+), between mutant Ras and WT ± S.E.  (n = 2). 
 
Table 2. Relative binding affinities between cRaf and various Ras(GTP) species as a fold 
difference vs. WT. Relative binding and kinetic values of mUbiRas compared to WT 
mUbRas104 mUbRas147 K104C K104C+TMAO WT+TMAO 
-3.34±0.87 -6.41±0.35 -6.46±1.18 -2.48±0.63 +1.06±0.50 
*mUbRas147 data obtained from R. Thurman13 
 
Rosetta modeling data shows mUbRas104 and mUbRas147 make contacts at distinct residues, 
explaining the differences in binding and activity data.   
 
Rosetta modeling done by J. Harrison of the Kuhlman show that mUbRas104 makes contacts 
primarily with switch II and helix 3, helping explain the observed perturbations and structural 
changes in that region. However, these contacts also indicate that the Ubiquitin molecule could 
have a crowding effect simply due to the steric bulk of the protein in that region, helping explain 
why its binding affinity to bRaf or Sos is not as weak as the RasK104C mutant.  The observed 
contacts for mUbRas147 are more prominent in switch I, and explain the observed GAP 
deficiencies.2  
 
 
 
Figure 6. (A:top) Lowest scoring 20 models of GDP-bound mUbRas104 (left) and mUbRas147 
(right) using Rosetta. Ras is in green and the isopeptide linked ubiquitin are multi-colored. 
Switch I (residues 26-38) is colored in blue and Switch 2 (residues 61-74) is colored in yellow. 
These models reveal that ubiquitin can adopt a spectrum of conformations while chemically 
conjugated to Ras. (bottom) Frequency of models that have a ubiquitin residue within 8Å of a 
residue on Ras. These frequencies are calculated from the top 580 (K104) or 814 (K147) models. 
Contacts with the Ras surfaces is in agreement with peak broadening seen in NMR for 
mUbRas104 and mUbRas147. Panel B contains the same analysis, but for GTP-bound mUbRas. 
(bottom) Frequencies for K104 and K147 are extracted from 1082 and 723 low-scoring models, 
respectively.   
 
Discussion:  
 
From the study of mUbRas104, it was found that monoubiquitination at the surface lysine of 
position 104 differs from modification at 147.  When modified at 104, the ubiquitin is free to 
sample a variety of conformations as predicted by the Rosetta modeling, but primarily comes in 
contact with switch II and helix 3. These contacts could help explain the variety of changes 
observed in those regions through 2D and 3D NMR analysis.  The mUbRas104 modification  
slightly weakens bRaf binding since it primarily binds through switch I, where there are some 
observed chemical shift perturbations and broadening, but these effects are small (roughly 3-fold 
weaker) when compared to bRaf binding to mUbRas147 (roughly 6-fold weaker binding).13 This 
observation is reflected in the Rosetta modeling data where ubiquitin is simulated to have many 
more contacts with switch I in mUbRas147 compared to mUbRas104. When compared to the 
unmodified mutant RasK104C, mUbRas104 shows 2-fold stronger binding relative to the mutant, 
but displays similar binding strength to bRaf when the crowding agent TMAO is added to the 
mutant.  Hence, the addition of 0.5 M TMAO to the trial with RasK104C in this assay was able to 
restore bRaf binding affinity of the mutant roughly 2-fold compared to the mutant without 
TMAO, which gives credit to the hypothesis of a crowding mechanism by ubiquitin in 
mUbRas104. 
 
This crowding explanation may help explain the observed increase in GEF exchange between 
RasK104C and mUbRas104 found through previous studies.6 While the RasK104C mutant may cause 
a significant loss of structure due to the mutation of a key lysine around the H2 and H3 region, 
preventing efficient GEF exchange, the crowding behavior of mUbRas104 may force a Ras to 
adopt a tighter conformation than the unmodified mutant due to an occlusion effect and restore 
GEF binding. The GEF we used, SosCat, primarily binds to Ras through switch II and H3 through 
electrostatic interactions with a few key residues on Ras: R102, V103, Q70, Y71, and R73.8 This 
site-specific binding between Ras-SosCat heavily relies on the positioning of these residues on H2 
and H3, but the mutation at K104, causes a loss of the electrostatic interaction between H2 and 
H3.  The loss of this key electrostatic interaction causes the two helices to adopt a more dynamic 
and open structure that hinders GEF binding.  
 
The Rosetta modeling predicts that Ubiquitin has numerous contacts with switch II and H3 in 
mUbRas104 which could lead to two explanations. Either Ubiquitin is interacting with Ras in a 
site-specific manner, causing the structural changes and forcing a tighter conformation, or 
Ubiquitin is essentially crowding the protein through an occlusion effect by occupying the space 
the switch and helix regions tend to open into after the loss of the lysine 104 electrostatic 
interaction. Since previous work using a large excess of Ubiquitin in the presence of Ras showed 
no site-specific interactions through NMR, the first explanation can be disregarded, which leads 
us postulate the second crowding interaction is the reason for observed effects.2 In addition, 
previous Rosetta modeling experiments have also predicted that the interactions are not specific 
to ubiquitin, but rather any small protein group PDZ2 modified at the same position are modeled 
to have the same effects, which reflects the second crowding mechanism where only a steric bulk 
is needed to cause the observed functional effects.2 
 
To further test our Ubiquitin crowding hypothesis, real time NMR experiments have been 
planned for RasK104C GEF exchange in the presence or absence of TMAO.  We hope to see the 
similar restoration of GEF activity when the Ras mutant is crowded with TMAO. If the ubiquitin 
molecule can indeed increase binding to dynamic regions of a protein simply by influencing 
conformational changes through steric bulk, then it would be a novel avenue of protein 
regulation for future exploration. These experiments would involve characterizing the dynamics 
of mUbRas104, which were attempted, but due to instability of the disulfide system when exposed 
to air for extended periods of time, the protein could not remain stable through prolonged NMR 
dynamic experiments.  The DCA method was developed to circumvent the flaws in the disulfide 
system and can be used in the future for these dynamic experiments. In addition, we hope to 
characterize the differences in the tightness of the conformation between RasK104C and 
mUbRas104 through radius of gyration measurements using DOSY NMR experiments. With a 
better understanding of the effects mUbRas has on protein dynamics and structure, the specific 
mechanism by which monoubiquitination can affect binding can be better determined. To 
confirm these in vitro observations, lysate pull-down assays can now be performed in future 
experiments to determine whether these monoubiquitination modifications has observable effects 
on cell proliferation. These experiments were previously not possible due to the sensitivity of the 
ubiquitination system to reducing agents; however, DCA generated mUbRas protein no longer 
has this issue and can be used in reducing environments. 
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